Mark Walshauser has Hematology/oncology as his primary medical specialty. Their primary office is: 12860 Troxler Ave in Highland, Illinois.
There is an additional office location, for a total of two, for Mark Walshauser that can be viewed further down.
They're a part of the: Cancer Care Specialists Of Central Illinois, S.c. medical group which has around 26 members. You can call their office at 618-651-2888 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2006 (around 18 years of experience). They are listed as doing telehealth appointments.
Mark Walshauser
Cancer Care Specialists Of Central Illinois, S.c.
12860 Troxler Ave
Highland, Illinois 62249
618-651-2888
Phone: 618-651-2888
Enter a starting address:
Medical School: Sorry, his university is not listed
Graduation Year: 2006
The Primary Medical Specialty for Mark Walshauser is listed as: Hematology/oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 0345365227
NPI #: 1306020664
NPI Created On: 12/21/2007
NPI Last Updated Listed as: 12/12/2023
Primary Taxonomy Code: 207R00000X
License Number:
2010024540
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $20
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788090933
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $24
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788090931
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $22
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788090935
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 799853893
Being Disputed:: No
Product Related: Yes
Drug or Biological: Device
Product Category #1: ONCOLOGY
Name of Drug #1: FOUNDATIONONE
Drug or Biological: Device
Product Category #2: ONCOLOGY
Name Of Drug #2:: FOUNDATIONONE HEME
Drug or Biological #3:: Device
Product Category #3: ONCOLOGY
Name of Drug: FOUNDATIONONE CDX
Drug or Biological: Device
Product Category #4: ONCOLOGY
Name of Drug #4: FOUNDATIONFOCUS
Drug or Biological #4:: Device
Product Category #5: ONCOLOGY
Name of Drug #5: FOUNDATIONONE LIQUID CDX
Payments Total: $24
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781016035
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $25
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781016037
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781016039
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781016041
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 796222337
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: VENCLEXTA
Open Associated Drug #1: 0074-0576-22
Payments Total: $11
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 818651805
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: VERZENIO
Open Associated Drug #1: 0002-6216-54
1. Cancer Care Specialists Of Central Illinois, S.c.
321 Regency Park
O Fallon, IL 62269
Suite 100
Group Members: 26
Phone: 618-651-2888
Enter a starting address:
12860 Troxler Ave
Highland, IL
Cancer Care Specialists Of Central Illinois, S.c.
9515 Holy Cross Ln
Breese Il 62230-3618
Cancer Care Specialists Of Central Illinois, S.c.
Nurse Practitioner
321 Regency Park
O Fallon Il 62269-1887
Cancer Care Specialists Of Central Illinois, S.c.
Nurse Practitioner
905 Medical Park Dr
Effingham Il 62401-2190
Cancer Care Specialists Of Central Illinois, S.c.
Radiation Oncology
1990 E Lake Shore Dr
Decatur Il 62521-3811
Cancer Care Specialists Of Central Illinois, S.c.
Radiation Oncology
210 W Mckinley Ave
Decatur Il 62526-5858
Cancer Care Specialists Of Central Illinois, S.c.
Radiation Oncology
905 Medical Park Dr
Effingham Il 62401-2190
Cancer Care Specialists Of Central Illinois, S.c.
Radiation Oncology
View all 26 members of Cancer Care Specialists Of Central Illinois, S.c. medical group